Trials / Conditions / Paranasal Sinus Squamous Cell Carcinoma
Paranasal Sinus Squamous Cell Carcinoma
5 registered clinical trials studyying Paranasal Sinus Squamous Cell Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin a NCT06662058 | Emory University | N/A |
| Completed | IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma NCT03381183 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Active Not Recruiting | Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer NCT03468218 | Emory University | Phase 2 |
| Completed | Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Can NCT03032250 | Wake Forest University Health Sciences | N/A |
| Terminated | Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer NCT01267240 | National Cancer Institute (NCI) | Phase 2 |